https://www.owkin.com | United States | 2016 | $334.1M
Owkin is a U.S.-based company specializing in applying AI technologies to clinical research for developing better drugs and treatments. The company integrates human and artificial intelligence to subtype patients, identify biomarkers, and inform drug discovery and diagnostic development. Owkin has partnerships with pharmaceutical companies like Sanofi, Bristol-Myers Squibb, and Merck to leverage its AI-powered capabilities.
